December 11, 2013 — For patients with stable coronary artery disease (CAD) who are not experiencing a heart attack and ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 25, 2013 – Combining genetic data with clinical information to determine the initial dosage of the blood ...
November 25, 2013
Feature | Dave Fornell
The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in ...
November 19, 2013November 15, 2013 — The American College of Cardiology (ACC) and the American Heart Association (AHA) released a ...
November 15, 2013November 15, 2013 — Resverlogix Corp. announced two additional results from the ongoing analysis of its Phase 2b ASSURE ...
November 15, 2013
November 15, 2013 — A study conducted in Ireland found that aspirin does not adequately protect 20 percent of patients ...
November 15, 2013November 14, 2013 — Professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug ...
November 14, 2013
November 8, 2013 — A new way of using blood pressure-lowering medications could prevent more than a fourth of heart ...
November 08, 2013By Dave Fornell, DAIC editor
The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) ...
November 08, 2013November 4, 2013 — According to a study of diabetic patients who underwent revascularization for multivessel coronary ...
November 04, 2013November 4, 2013 — A new study demonstrated that some patients may not need to receive prolonged anti-clotting therapy ...
November 04, 2013
November 4, 2013 — Patients who do not experience a major cardiac event in the first year after receiving drug-eluting ...
November 04, 2013
November 4, 2013 — According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention ...
November 04, 2013
November 1, 2013 — According to a new study, administering the blood thinner bivalirudin to patients experiencing an ST ...
November 01, 2013
October 31, 2013 — Abbott announced it plans to initiate a randomized, controlled trial in the United States to evaluate ...
October 31, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now